APPLICATION
ANDA074585
TYPE
ANDA
ORIGINAL APPROVAL
1996-09-26
LATEST ACTION
2002-11-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
INDAPAMIDEDiscontinued
INDAPAMIDE 1.25MG · TABLET · ORAL
INDAPAMIDEDiscontinued
INDAPAMIDE 2.5MG · TABLET · ORAL
Approval history
2002-11-07Manufacturing (CMC) · Supplement 7AP
2002-08-28Manufacturing (CMC) · Supplement 6AP
2002-08-28Manufacturing (CMC) · Supplement 5AP
2001-09-05Manufacturing (CMC) · Supplement 4AP
1999-11-10Manufacturing (CMC) · Supplement 3AP
1998-08-06Manufacturing (CMC) · Supplement 1AP
1998-04-08Labeling · Supplement 2AP
1996-09-26OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.